China is investing record amounts of money into U.S.-based healthcare and pharmaceutical startups, as it seeks to become a powerhouse in developing new medicines.
China is investing record amounts of money into U.S.-based healthcare and pharmaceutical startups, as it seeks to become a powerhouse in developing new medicines.